The polycystic ovary syndrome: treatment with insulin sensitizing agents
- 1 May 1999
- journal article
- review article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 1 (3), 127-136
- https://doi.org/10.1046/j.1463-1326.1999.00026.x
Abstract
No abstract availableThis publication has 60 references indexed in Scilit:
- Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected WomenJournal of Clinical Endocrinology & Metabolism, 1999
- Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective StudyJournal of Clinical Endocrinology & Metabolism, 1998
- Hyperandrogenic anovulation (PCOS): A unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitusAmerican Journal Of Medicine, 1995
- Evidence for Distinctive and Intrinsic Defects in Insulin Action in Polycystic Ovary SyndromeDiabetes, 1992
- Cellular mechanisms of insulin resistance in polycystic ovarian syndromeJournal of Clinical Endocrinology & Metabolism, 1992
- Insulin Resistance, Hyperinsulinemia, Hypertriglyceridemia, and Hypertension: Parallels Between Human Disease and Rodent ModelsDiabetes Care, 1991
- Risk Factors for Coronary Artery Disease in Healthy Persons with Hyperinsulinemia and Normal Glucose ToleranceNew England Journal of Medicine, 1989
- Insulin-Signaling Mechanisms: Lessons From the Old Testament of Glycogen Metabolism and the New Testament of Molecular BiologyDiabetes, 1988
- Insulin Resistance in Nonobese Patients with Polycystic Ovarian Disease*Journal of Clinical Endocrinology & Metabolism, 1983
- Mediators of postreceptor action of insulinAmerican Journal Of Medicine, 1983